Psoriasis patients’ preference for an aerosol foam topical formulation Journal Articles

abstract

• Linked article: This article is commentary on by C‐H. Hong et al., pp. e401–e402 in this issue. To view this article visithttps://doi.org/10.1111/jdv.14985

authors

• Vender, Ronald
• Gooderham, MJ
• Guenther, LC
• Kyritsis, D
• Rao, J
• Kowalczyk, A
• Ashkenas, J

status

• published 

publication date

• November 2018

has subject area

• 1103 Clinical Sciences (FoR)
• Administration, Cutaneous (MeSH)
• Dermatologic Agents (MeSH)
• Dermatology & Venereal Diseases (Science Metrix)
• Humans (MeSH)
• Patient Preference (MeSH)
• Pharmaceutical Vehicles (MeSH)
• Psoriasis (MeSH)

published in

• Journal of the European Academy of Dermatology and Venereology  Journal

keywords

• Administration, Cutaneous
• Dermatologic Agents
• Humans
• Patient Preference
• Pharmaceutical Vehicles
• Psoriasis

Digital Object Identifier (DOI)

• 10.1111/jdv.14993

PubMed ID

• 29633366

start page

• e400

end page

• e401

volume

• 32

issue

• 11